Bad to worse for Applied Therapeutics as FDA slaps partial clinical hold on rare drug

The FDA has hit Applied Therapeutics with a partial clinical hold for its experimental galactosemia drug AT-007.

This comes around six weeks after a short report attacking the New York biotech floated onto Twitter and through a blog from Biotech Research Partners.